Search
| GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
|---|---|---|---|---|---|
| finn-b-C3_LYMPHNODES_SECONDARY_NAS | 2021 | Secondary and unspecified malignant neoplasm of lymph nodes | NA | — | 16,380,466 |
| finn-b-C3_LYMPHNODES_SECONDARY_NAS_EXALLC | 2021 | Secondary and unspecified malignant neoplasm of lymph nodes (all cancers excluded) | NA | — | 16,380,304 |
| finn-b-I9_HYPTENSEC | 2021 | Secondary hypertension | NA | — | 16,380,172 |
| finn-b-I9_HYPTENSEC_EXNONE | 2021 | Secondary hypertension (no controls excluded) | NA | — | 16,380,466 |
| finn-b-C3_SECONDARY_NAS | 2021 | Secondary malignant neoplasm of other and unspecified sites | NA | — | 16,380,466 |
Data overview
The GWAS summary datasets information is not available at this time.